Literature DB >> 20185534

Clinical features, treatments and prognosis of the initial cases of pandemic influenza H1N1 2009 virus infection in Shanghai China.

Y P Mu1, Z Y Zhang, X R Chen, X H Xi, Y F Lu, Y W Tang, H Z Lu.   

Abstract

BACKGROUND AND
OBJECTIVE: As of 13 December 2009, more than 208 countries and overseas territories or communities have reported laboratory-confirmed cases of pandemic influenza H1N1 2009, which have resulted in at least 10 582 deaths. As of 7 December 2009, 4328 severe cases were reported in Mainland China, resulting in 326 deaths. This study's objective was to determine the clinical features, treatments and prognosis of the initial cases of Pandemic influenza H1N1 2009 virus infection in Shanghai, China, and how its clinical features related to patient gender.
METHODS: A total of 224 confirmed 2009 influenza A/H1N1-infected patients treated and discharged by Shanghai Public Health Clinical center between 24 May and 20 July 2009 were included in the study. Patients' personal information, signs and symptoms, laboratory and imagery data, disease course, hospitalization period and seroconversion duration for viral nucleic acid after antiviral treatment were analyzed.
RESULTS: Among the 224 patients, 118 were male and 106 were female, yielding a sex ratio of 1.1:1. Approximately 52% of the patients came from Australia, and 63.8% were between 18 and 40 years old. Clinical manifestations included fever, cough and congestion of the throat, and lab findings were characterized by elevated C-reaction protein (CRP) and neutrophils. Female patients had significantly lower serum Prealbumin (PA) levels than male patients (P < 0.05). The patients' serum CRF levels significantly decreased after treatment (P < 0.05), while the levels of CD3, CD4 and CD8 significantly increased after treatment (P < 0.01). Approximately 29.9% of the patients had abnormal signs on chest computer tomography scan, and 21.9% had obvious signs indicating pneumonia. However, blood cultures were negative in these patients. The average disease course was 3.9 +/- 1.4 days, the average hospitalization period was 5.0 +/- 1.7 days, and the seroconversion duration for viral nucleic acid after antiviral treatment was 3.8 +/- 1.3 days.
CONCLUSION: Initial cases of pandemic influenza H1N1 2009 were characterized by fever, cough and throat congestion, with elevated CRP and neutrophils being the most significant lab findings. The pandemic influenza H1N1 2009 strain was able to affect multiple organs, including the hepatic synthesis of PA and immune functioning. The novel 2009 Influenza A/H1N1 virus was mild clinically, with a short disease course and good prognosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185534     DOI: 10.1093/qjmed/hcq012

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  10 in total

Review 1.  The role of rapid antigen testing for influenza in the era of molecular diagnostics.

Authors:  Suzanne E Dale
Journal:  Mol Diagn Ther       Date:  2010-08-01       Impact factor: 4.074

2.  Clinical factors predictive of pneumonia caused by pandemic 2009 H1N1 influenza virus.

Authors:  Sawan Kanchana; Supannakhon Kanchana; Teerapon Vijitsopa; Kreeta Thammakumpee; Sukit Yamwong; Kittisak Sawanyawisuth
Journal:  Am J Trop Med Hyg       Date:  2013-02-04       Impact factor: 2.345

3.  Clinical characteristics of critical patients with pandemic influenza A (H1N1) virus infection in Chengdu, China.

Authors:  Li-hui Deng; Yi-lan Zeng; Ping Feng; Ya-ling Liu; Li-chun Wang; Yun Bai; Hong Tang
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

4.  Complex febrile seizures followed by complete recovery in an infant with high-titer 2009 pandemic influenza A (H1N1) virus infection.

Authors:  Mandy F O'Leary; James D Chappell; Charles W Stratton; Robert M Cronin; Mary B Taylor; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

Review 5.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  A Two Wave Analysis of Hospitalizations and Mortality from Seasonal and Pandemic 2009 A (H1N1) Influenza in Saurashtra, India: 2009-2011.

Authors:  Rk Chudasama; Uv Patel; Pb Verma; A Banerjee; P Buch; P Patel
Journal:  Ann Med Health Sci Res       Date:  2013-07

7.  Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults.

Authors:  Thomas Bewick; Puja Myles; Sonia Greenwood; Jonathan S Nguyen-Van-Tam; Stephen J Brett; Malcolm G Semple; Peter J Openshaw; Barbara Bannister; Robert C Read; Bruce L Taylor; Jim McMenamin; Joanne E Enstone; Karl G Nicholson; Wei Shen Lim
Journal:  Thorax       Date:  2011-01-20       Impact factor: 9.139

8.  Clinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax,Tunisia.

Authors:  Hassen Damak; Kamilia Chtara; Mabrouk Bahloul; Hatem Kallel; Anis Chaari; Hichem Ksibi; Adel Chaari; Hedi Chelly; Noureddine Rekik; Chokri Ben Hamida; Mounir Bouaziz
Journal:  Influenza Other Respir Viruses       Date:  2011-01-31       Impact factor: 4.380

9.  Clinical Characteristics of Adult Fevered COVID-19 Patients and Predictors for Developing Severe Events.

Authors:  Guyi Wang; Quan Zhang; Chenfang Wu; Fang Wu; Bo Yu; Jianlei Lv; Siye Zhang; Guobao Wu; Yanjun Zhong
Journal:  Front Med (Lausanne)       Date:  2020-07-03

10.  Prognosis of 18 H7N9 avian influenza patients in Shanghai.

Authors:  Shuihua Lu; Tao Li; Xiuhong Xi; Qingguo Chen; Xuhui Liu; Binxing Zhang; Jiaxian Ou; Jie Liu; Qin Wang; Biao Zhu; Xinian Liu; Chunxue Bai; Jieming Qu; Hongzhou Lu; Zhiyong Zhang; Yuanlin Song
Journal:  PLoS One       Date:  2014-04-02       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.